523 (Cefpodoxime 200 mg)
Pill imprint 523 has been identified as Cefpodoxime proxetil 200 mg.
Cefpodoxime is used in the treatment of skin infection; bronchitis; bladder infection; gonococcal infection, disseminated; otitis media (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Cefpodoxime 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 523
More about cefpodoxime
- Other brands: Vantin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.